Executive order 14042 - illumina INC:1107104 [22-003510] - the genomic technology section within niams requests the purchase of sequencing reagent kits for our illumina novaseq 6000 and nextseq 550…
Ended Awarded Last action
- Contract number
- 75N92B22F20007
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $174,225
Award facts
- Contract value 100% obligated
- $174,225.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $174,225 |
About this award
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $174,225.46 firm fixed price delivery order to Illumina, Inc. for the purchase of sequencing reagent kits to support the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencers. This award was not set aside. Illumina is a manufacturer of genomic sequencing and analytical instruments, and has provided a range of sequencing systems, reagents, and services to support research and diagnostic needs across multiple federal agencies, including the NIH, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs. The agency indicates these sequencing reagents are extremely essential to ongoing operations.
Description
Executive order 14042 - illumina INC:1107104 [22-003510] - the genomic technology section within niams requests the purchase of sequencing reagent kits for our illumina novaseq 6000 and nextseq 550 sequencers. These kits are extremely essential to CO
Quick answers
Who was awarded contract 75N92B22F20007?
75N92B22F20007 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on July 21, 2022.
How much is contract 75N92B22F20007 worth?
The government has obligated $174,225 on 75N92B22F20007.
Is contract 75N92B22F20007 an order under another contract?
Yes. 75N92B22F20007 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92B22F20007 competed?
The extent of competition for 75N92B22F20007 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award